Airsupra Interactions
There are 866 drugs known to interact with Airsupra (albuterol/budesonide), along with 12 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 87 are major, 752 are moderate, and 27 are minor.
- View all 866 medications that may interact with Airsupra
- View Airsupra alcohol/food interactions (3)
- View Airsupra disease interactions (12)
Most frequently checked interactions
View interaction reports for Airsupra (albuterol / budesonide) and the medicines listed below.
- albuterol
- atorvastatin
- azelastine nasal
- Breztri Aerosphere (budesonide / formoterol / glycopyrrolate)
- bupropion
- cyclobenzaprine
- famotidine
- Flonase (fluticasone nasal)
- gabapentin
- hydroxyzine
- ibuprofen
- levothyroxine
- magnesium oxide
- metformin
- montelukast
- Nurtec ODT (rimegepant)
- omeprazole
- ondansetron
- pantoprazole
- prednisone
- propranolol
- rosuvastatin
- Singulair (montelukast)
- Symbicort (budesonide / formoterol)
- tizanidine
- trazodone
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Airsupra alcohol/food interactions
There are 3 alcohol/food interactions with Airsupra (albuterol / budesonide).
Airsupra disease interactions
There are 12 disease interactions with Airsupra (albuterol / budesonide) which include:
- cardiovascular
- diabetes
- hypokalemia
- seizures
- hepatic impairment
- infections
- lactose intolerance
- ocular herpes simplex
- ocular toxicities
- osteoporosis
- hyperadrenocorticism
- renal dysfunction
Report options
QR code containing a link to this page
More about Airsupra (albuterol / budesonide)
- Airsupra consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (8)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antiasthmatic combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
